They have created the COMBAT BRS and COMBAT PRS systems, which deliver Hyperthermic Intra-Vesical Chemotherapy and Hyperthermic Intraperitoneal Chemotherapy, respectively. These systems offer significant improvements in the effectiveness of treatment for Non Muscle Invasive Bladder Cancer and cancers within the peritoneal cavity. The company has been investing heavily in clinical trials and research and has been in clinical use since 2011. For more information, visit their website or contact them directly.